AILNP
LIVE

Serial Number

97636213

Owner

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD

Attorney

Mark E. Bandy

First Use Date

Oct 22, 2022

Filing Date

Oct 18, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AILNP Trademark

Serial Number: 97636213 • Registration: 7755187

AILNP is a trademark filed by HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD on October 18, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HANGZHOU JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD (6 trademarks)

Room 116, 1st Floor, Building 2,

Entity Type: 03

BEIJING JITAI PHARMACEUTICAL TECHNOLOGY CO.,LTD (4 trademarks)

ROOM 307, 3RD FLOOR,

Entity Type: 03

METIS TECHBIO CO., LTD.

ROOM 201, 2ND FLOOR, BUILDING 13, NO. 21 TIANHE WEST ROAD, ZHONGGUANCUN SCIENCE PARK DAXING BIOMEDICAL INDUSTRY BASE, DAXING DISTRICT
BEIJING 102600 , CN

Entity Type: 99

Trademark Details

Filing Date

October 18, 2022

Registration Date

April 8, 2025

First Use Anywhere

October 22, 2022

First Use in Commerce

October 22, 2022

Published for Opposition

October 24, 2023

Goods & Services

Design of computer databases; conversion of computer programs and data, other than physical conversion; digitization of documents being scanning; computer programming in medical care; providing virtual computer systems through cloud computing; pharmaceutical drug development; drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; pharmaceutical research; scientific research and development; conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; computer hardware design; research and development of new products for others; providing computer software design for others; electronic data storage; conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; conversion of data or documents from physical to electronic media; clinical trials, namely, scientific research in the nature of conducting clinical trials for others; animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; computer programming

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 22, 2026 ASGN
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 8, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 8, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 17, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 17, 2025 CNPR
ASSIGNED TO LIE
Jan 11, 2025 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 10, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Sep 10, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 3, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 3, 2024 AITU
USE AMENDMENT FILED
Jun 17, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Jun 17, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 19, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 24, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 24, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2023 CNSA
ASSIGNED TO EXAMINER
Sep 18, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 17, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 17, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 17, 2023 CNRT
ASSIGNED TO EXAMINER
May 2, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 1, 2022 NWOS
NEW APPLICATION ENTERED
Oct 21, 2022 NWAP